浸润性乳腺癌及不同分子分型病人的血脂水平分析

殷发祥; 钱军; 殷发祥; 钱军

doi:10.13898/j.cnki.issn.1000-2200.2020.01.021

[1]

MARTIN LJ, MELNICHOUK O, HUSZTI E, et al.Serum lipids, lipopro-teins, and risk of breast cancer:a nested case-control study using multiple time points[J].J Natl Cancer Inst, 2015, 107(5):djv032.

[2]

NELSON ER, CHANG CY, MCDONNELL DP.Cholesterol and breast cancer pathophysiology[J].Trends Endocrinol Metab, 2014, 25(12):649.

[3]

RYU HM, JEONG YS, YIM CS, et al.Quantification of EC-18, a synthetic monoacetyldiglyceride(1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol), in rat and mouse plasma by liquid-chromatography/tandem mass spectrometry[J].J Pharm Biomed Anal, 2017, 15(137):155.

[4]

KITAHARA CM, BERRINGTON DE, GONZALEZ A, et al.Total cholesterol and cancer risk in a large prospective study in Korea[J].J Clin oncol, 2011, 29(12):1592.

[5]

BAHL M, ENNIS M, TANNOCK IF, et al.Serum lipids and outcome of early-stage breast cancer:results of a prospective cohort study[J].Breast Cancer Res Treat, 2005, 94(2):135.

[6]

郭莉, 刘鹏熙, 司徒红林, 等.血脂、体质量指数与受体双阴性乳腺癌预后关系的临床研究[J].广州中医药大学学报, 2010, 27(2):103.

[7]

姚宇锋, 唐金海, 秦建伟.脂质代谢紊乱对乳腺癌复发转移的影响[J].现代肿瘤医学, 2011, 19(12):2454.

[8]

曹培.血脂代谢水平和乳腺癌发病风险的病例对照研究[J].临床医药文献杂志, 2018, 5(76):107. doi: 10.3760/cma.j.issn.0253-9624.2016.12.013

[9]

沈俊俊, 潘月芬, 钟丽萍, 等.浸润性乳腺癌的血脂代谢特点及其与分子分型的关系研究[J].中国卫生检验杂志, 2018, 28(19):2352.

[10]

LAISUPASIN P, THOMPAT W, SUKARAYODHIN S, et al.Comparison of serum lipid profiles between normal controls and breast cancer patients[J].J Lab Physicians, 2013, 5(1):38.

[11]

亓建波, 马家驰, 郭庆金, 等.血脂水平与乳腺恶性肿瘤的关系[J].现在肿瘤医学, 2017, 25(2):290.

[12]

STROHMAIER S, EDLINGER M, MANJER J, et al.Total serum cholesterol and cancer incidence in the metabolic syndrome and cancer project(Me-Can)[J].PLoS One, 2013, 8(1):e54242.